Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase II Sunitinib Prog Met AIPC

ClinicalTrials.gov ID: NCT00599313

Public ClinicalTrials.gov record NCT00599313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Sunitinib Malate for the Therapy of Progressive Metastatic Androgen Independent Prostate Cancer (AIPC) Following Docetaxel-based Chemotherapy

Study identification

NCT ID
NCT00599313
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
36 participants

Conditions and interventions

Interventions

  • Sunitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
May 31, 2009
Completion
May 31, 2009
Last update posted
Oct 24, 2018

2007 – 2009

United States locations

U.S. sites
45
U.S. states
18
U.S. cities
42
Facility City State ZIP Site status
Hematology Oncology Associates Phoenix Arizona 85012
Connecticut Oncology & Hematology, LLP Torrington Connecticut 06790
Ocala Oncology Center Ocala Florida 34474
Cancer Care & Hematology Specialista of Chicagoland Niles Illinois 60714
Hope Center Terre Haute Indiana 47802
Maryland Oncology Hematology, P.A. Columbia Maryland 21044
Alliance Hematology Oncology PA Westminster Maryland 21157
Missouri Cancer Associates Columbia Missouri 65201
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507
Arch Medical Services, Inc. DBA The Cntr for Cancer Care & Research St Louis Missouri 63141
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
NH Oncology-Hematology PA Hooksett New Hampshire 03106
New Mexico Cancer Care Associates Santa Fe New Mexico 87505
New York Oncology Hematology, P.C. Albany New York 12206
Interlakes Oncology Hematology, PC Rochester New York 14623
Cancer Centers of North Carolina Raleigh North Carolina 27607
Greater Dayton Cancer Center Kettering Ohio 45409
Medical Oncology Associates Kingston Pennsylvania 18704
Cancer Centers of the Carolinas Greenville South Carolina 29605
Texas Cancer Center-Abilene(South) Abilene Texas 79606
Texas Oncology, P.A.-Amarillo Amarillo Texas 79106
Texas Cancer Center Arlington Texas 76014
Texas Oncology Cancer Center Austin Texas 78731
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702
Texas Oncology, P.A.-Bedford Bedford Texas 76022
Texas Cancer Center at Medical City Dallas Texas 75230
Texas Onclogy, P.A. Dallas Texas 75231
Methodist Charlton Cancer Ctr. Dallas Texas 75237
Texas Oncology, P.A. Dallas Texas 75246
Texas Cancer Center Denton Texas 76210
El Paso Cancer Treatment Ctr El Paso Texas 79915
Texas Oncology, P.A. Fort Worth Texas 76104
Allison Cancer Center Midland Texas 79701
Texas Oncology-Odessa Odessa Texas 79761
Paris Regional Cancer Center Paris Texas 75460
HOAST-Medical Dr. San Antonio Texas 78229
Texas Oncology Cancer Center-Sugar Land Sugar Land Texas 77479
Texas Oncology Cancer Care and Research Waco Texas 76712
Texas Oncology, P.A. Webster Texas 77598
Virginia Oncology Associates Norfolk Virginia 23502
Onc and Hem Associates of SW VA, Inc. Salem Virginia 24153
Puget Sound Cancer Center-Edmonds Edmonds Washington 98026
Puget Sound Cancer Center-Seattle Seattle Washington 98133
Northwest Cancer Specialists-Vancouver Vancouver Washington 98684
Yakima Valley Mem Hosp/North Star Lodge Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00599313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2018 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00599313 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →